| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |